本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

156.22
-0.3500-0.22%
盤後156.220.00000.00%19:47 EDT
成交量:89.09萬
成交額:1.40億
市值:159.34億
市盈率:22.90
高:159.67
開:157.20
低:156.12
收:156.57
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.00
換手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.31
市盈率(LYR):33.45

資料載入中...

2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

重要事件披露

Current report, items 2.02, 5.02, 5.03, and 9.01
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/11

超過5%披露

General statement of acquisition of beneficial ownership
2019/12/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/10/16

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/10/04

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/09/12

持股變動聲明

Initial statement of beneficial ownership of securities
2019/09/12

持股變動聲明

Statement of changes in beneficial ownership of securities